BOOSTRIX 8 ug/.5mL
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed · SUSPENSION · A-S Medication Solutions
BOOSTRIX is a suspension containing tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed at 8 ug/.5mL, taken intramuscular. Manufactured by A-S Medication Solutions.
Key Facts
- Brand Name
- BOOSTRIX
- Generic Name
- Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed
- NDC Code (Product)
50090-1831- Manufacturer
- A-S Medication Solutions
- Strength
- 8 ug/.5mL
- Dosage Form
- SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125106
- Marketing Start
- 07/24/2009
Recall History
No Recall HistoryFrequently Asked Questions
What is BOOSTRIX used for?
BOOSTRIX contains Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed. It is a suspension taken intramuscular. Consult your doctor for specific uses.
Is BOOSTRIX a controlled substance?
BOOSTRIX is not classified as a controlled substance by the DEA.
What is the generic name for BOOSTRIX?
The generic name for BOOSTRIX is Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed. There are no other listed brand versions of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed.
What is the NDC code for BOOSTRIX 8 ug/.5mL?
The NDC (National Drug Code) for BOOSTRIX 8 ug/.5mL is 50090-1831, listed by A-S Medication Solutions.
Other BOOSTRIX Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)